Nephrology
Renal Consult
Proteinuria and Albuminuria: What’s the Difference?
Proteinuria and albuminuria are not the same thing—but they’re both important. Here’s how to “read” the lab report.
Renal Consult
Acute Kidney Injury: Treatment Depends on the Cause
What exactly is acute kidney injury? Our expert explains how to identify and manage this spectrum of conditions affecting the kidney.
News
FDA adds diabetic kidney disease, heart failure indications to canagliflozin
This marks the first time in 20 years that a drug has been indicated for diabetic kidney disease treatment, according to the manufacturer.
News
USPSTF: Screening pregnant women for asymptomatic bacteriuria cuts pyelonephritis risk
But the new recommendations urge clinicians to refrain from testing asymptomatic nonpregnant women and adult men.
News
Farxiga gets Fast Track status from FDA
Conference Coverage
Urine albumin testing is crucial for patients at risk for CKD, but drop the 24-hour urine test
SAN DIEGO – An update on diagnosing, managing, and treating patients with comorbid hypertension and diabetes.
News
No increase in UTI risk with SGLT-2 inhibitors
compared...
Conference Coverage
DECLARE-TIMI58 shows improved kidney function with dapagliflozin
SAN FRANCISCO – The SGLT2 dapagliflozin was better than placebo at slowing down kidney disease in patients with type 2 diabetes
News
NOACs benefit early stage chronic kidney disease patients
NOACs reduced risk of several adverse events compared with VKAs in a meta-analysis of chronic kidney disease patients.
News
The costs and benefits of SGLT2 inhibitors & GLP-1 RAs
The price tags on these drugs are the biggest barrier to their use.